Best SHOCK Oral Abstracts

Welcoming Remarks

Peripheral Blood Neutrophil-to-Lymphocyte Ratio is Associated with Mortality across the Spectrum of Cardiogenic Shock Severity

Yishay Szekely, MD

Management and outcomes of myocarditis with cardiogenic shock due to multisystem inflammatory syndrome in adults following COVID-19 – a single center experience

Dr. Retesh Bajaj, MBBS BSc PhD

Survival advantage of an intra-aortic balloon pump, YES, NO or an unsolved riddle

Mahesh Kumar Batra, M.B.B.S.

Contemporary Data and Science: Part 1

Welcoming Remarks

William W. O'Neill, MD, MSCAI

Cardiogenic Shock Working Group Update

Navin K. Kapur, M.D., FSCAI

National Cardiogenic Shock Initiative

William W. O'Neill, MD, MSCAI

DanGer Shock Trial

Jacob Moller, M.D.

Japanese-PVAD Registry

Junya Ako, MD, PhD

HERACLES Trial

Divaka Perera, M.D.

Contemporary Data and Science: Part 2

Welcoming Remarks

Roxana Mehran, M.D., MSCAI

“Real-World” Registries

Alexander G. Truesdell, M.D., FSCAI

RECOVER III: Women and Shock

Alexandra J. Lansky, M.D., MSCAI

RECOVER IV Trial

Gregg W. Stone, M.D.

Super-saturated Oxygen After Support

Babar B Basir, DO, FSCAI

American Heart Initiative on Cardiogenic Shock

Mariell Jessup, M.D.

Contemporary Data and Science: Part 3

Welcoming Remarks

Holger Thiele, MD

ECLS-SHOCK

Holger Thiele, MD

CABG-SHOCK

Andreas Boening, M.D.

ANCHOR

Gilles Montalescot, MD, PhD

EUROSHOCK

Marcus Flather, M.D.

CSRC Cardiogenic Shock Think Thank 2021 Update

Overview of CSRC Cardiogenic Shock Think Tank

Mitchell W. Krucoff, M.D., FSCAI

FDA Priorities for Shock 2021-2022

Nicole Gillette

Shock Academic Research Consortium Update

Ron Waksman, M.D.

Informed Consent for Shock Research

Nick E.J. West, MD

International Research Networks

Alastair Proudfoot, MBBS, PhD

CSRC and AHA Shock Initiative

David A. Morrow, MD, MPH

Panel Discussion

Disparities in Care and Advocacy Initiatives

Welcoming Remarks

Wayne B. Batchelor, M.D., FSCAI

Women and Shock

Sara Cecilia Martinez, M.D., Ph.D., FSCAI

Underrepresented Minorities and Shock

Nasrien E. Ibrahim, MD

Disparities Across the US

Alejandro Lemor, M.D., FSCAI

Advocacy and Legislation

J. Jeffrey Marshall, M.D., MSCAI

ECMO for the Cardiologist

Introductory Remarks

Stacey H. Brann, MD

Case Presentation, Part 1

Pedro A Villablanca, M.D., FSCAI

Program Building: How to Get Started 

Allison G. Dupont, M.D., FSCAI

ECMO vs. ECPR: What’s the Difference? 

Timothy D. Smith, M.D., FSCAI

Selection, Selection, Selection…Who to Place on ECMO?

Erik C. Osborn, MD

Weaning and Exit Strategies

Stacey H. Brann, MD

Case Conclusion, Part 2

Pedro A Villablanca, M.D., FSCAI

Panel Discussion

Concluding Remarks

Erik C. Osborn, MD

MCS in Treating Left, Right, and Bi-Ventricular Shock

Introductory Remarks

Rajan A. Patel, M.D., FSCAI

How and When to Escalate MCS

Daniel Burkhoff, M.D., PhD

Left-Sided MCS With LA-AO Pump: How It Works, Case Selection, Pros and Cons

Khaldoon Alaswad, M.D., FSCAI

Right-Sided MCS With RA-PA Pump: How It Works, Case Selection, Pros and Cons

Timothy D. Smith, M.D., FSCAI

Bi-Ventricular MCS With LA-AO and RA-PA Pumps: How It Works, Case Selection, Pros and Cons

Amir Kaki, M.D., FSCAI

V-A ECMO: How It Works, Case Selection, Pros and Cons

Elsayed Abo-Salem, M.D.

Concluding Remarks

Rajan A. Patel, M.D., FSCAI

Multidisciplinary Team-Based Approach to Cardiogenic Shock

Introductory Remarks

David H Wohns, M.D., FSCAI

Case Presentation, Part 1

Mohammad Zaidan, MD

The National CSI Approach

Babar B Basir, DO, FSCAI

Focus on Escalation

Michele Voeltz, M.D.

The California Way

Dr. Aditya Bharadwaj, M.B.B.S., FSCAI, Joshua Chung, MD, Antoine Sakr, MD

Case Conclusion, Part 2

Mohammad Zaidan, MD

Optimizing Antiplatelet Therapy in Cardiogenic Shock

Introductory Remarks

Case Presentation

Suzanne J. Baron, M.D., FSCAI

Anti-platelet Concerns and Pharmacodynamics in Cardiogenic Shock

George D. Dangas, M.D., Ph.D., MSCAI

Cangrelor: Trial Data, Indications, and Contraindications

Deepak L. Bhatt, M.D., M.P.H., MSCAI

Optimal “Recipe” for Antiplatelet Management in Shock: Present and Future

Jolanta Maria Siller-Matula, MD, PhD

 Case Presentation With Questions

Suzanne J. Baron, M.D., FSCAI

Practical Interpretation of Shock Hemodynamics

Introductory Remarks

Daniel Burkhoff, M.D., PhD

Case 1 Presentation

Pooja M. Swamy, MD, FSCAI

Case 1 Conclusion

Pooja M. Swamy, MD, FSCAI

Case 2 Presentation

Lorenzo Azzalini, MD, PhD, MSc, FSCAI

Case 2 Conclusion

Lorenzo Azzalini, MD, PhD, MSc, FSCAI

Case 3 Presentation

Jacob Abraham, MD

Case 3 Conclusion

Jacob Abraham, MD

Concluding Remarks

Shock Critical Care

Welcoming Remarks

Angela Taylor, M.D.

Shock Critical Care

Susanna Price, MBBS

Right Ventricular Shock: Support and Lysis

Behnam N. Tehrani, M.D.

Escalation and Weaning in Refractory Shock

Albert James Hicks III, MD, MPH

Futility: When is Enough Enough?

Shashank Sinha, MD, MSc

Shock Diagnosis and Treatment

Program Chair Welcome

William W. O'Neill, MD, MSCAI

Revised SCAI Shock Definitions 2021

Timothy D. Henry, M.D., MSCAI

Mastery of Advanced Hemodynamics

Daniel Burkhoff, M.D., PhD

Inotropes and Pressors

Robert O. Roswell, MD

MCS: Who, What, When, How?

Babar B Basir, DO, FSCAI

Shock Protocols, Teams, Centers, and Networks

Welcoming Remarks

Alexander G. Truesdell, M.D., FSCAI

Shock Protocols

Alastair Proudfoot, MBBS, PhD

Shock Teams - Who are the Players?

Jason Neil Katz, MD

Shock Complicated by Cardiac Arrest

Demetri Yannopoulos, M.D., FSCAI

Spoke-and-Hub Networks and Transfers

Carolyn M. Rosner, MSN, RN, FNP-BC

Super-Saturated Oxygen Therapy in AMI and Cardiogenic Shock

Introduction to SSO2 

Richard Schatz, M.D.

The Science of Infarct Reduction and Improving Microvascular Flow With SSO2 

Gregg W. Stone, M.D.

AMI Case Example & Discussion

Steven J. Yakubov, M.D., MSCAI

AMI #2 Case Example & Discussion

James Spears, MD

SSO2 in Cardiogenic Shock

Babar B Basir, DO, FSCAI

Panel Discussion

The Dark Side of The Moon: Non-Ischemic Shock

Introductory Remarks

David A. Baran, M.D., FSCAI

Non-Ischemic Shock: Pathophysiology and Recent Insights

Susanna Price, MBBS

IABP in Non-ischemic Shock

Corstiaan den Uil, MD, PhD

Impella in Non-ischemic Shock

Babar B Basir, DO, FSCAI

V A ECMO: One Size Fits All

Shelley Hall, M.D.

Case Presentation

Abhishek Jaiswal, M.B.B.S.

Panel Discussion

Concluding Remarks

Shelley Hall, M.D.

Top-Shock: Case Presentations

Welcoming Remarks

The “Double-Barrel” Impella CP (DBCP): A Novel Option in the Mechanical Circulatory Support Toolbox

Alec Vishnevsky, M.D.

Acute Papillary Muscle rupture in STEMI complicated by Cardiogenic shock during the Covid-19 era

Mohit Pahuja, MD

Left Atrial Veno-Arterial (LAVA) ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI

Pedro A Engel Gonzalez, M.D., FSCAI

World View on Cardiogenic Shock Management: Part 1

Welcoming Remarks

Mirvat Alasnag, M.D., FSCAI

German Perspective

Alexander Ghanem, MD, PhD

Italian Perspective

Giuseppe Tarantini, MD, PhD

Canadian Perspective

Derek So, M.D.

Latin American Perspective

Libardo Augusto, M.D.

World View on Cardiogenic Shock Management: Part 2

Welcoming Remarks

Ashok Seth, FRCP,, MSCAI

Australia-New Zealand Perspective

Gemma Figtree, MD

Japanese Perspective

Makiko Nakamura, MD, PhD

Indian Perspective

Suresh Rao K G, M.D.

Saudi Arabia Perspective

Khaled Al-Shaibi, M.D.

2021 SCAI SHOCK

SCAI SHOCK